Federal award (BPA CALL, fiscal year 2021)
Recipient: PROGENICS PHARMACEUTICALS INC
Awarding agency: Department of Defense / Department of the Navy
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-06-02 to 2022-06-02
Current total value of award: $49189.98
Description: PILARIFY (PIFLUFOLASTAT F-18) INJECTION QTY. 14